Filter Ventilation for Tobacco Use
Trial Summary
What is the purpose of this trial?
This open label, between-subject, randomized multi-center pilot study will assess the feasibility of conducting a study remotely with telehealth visits to assess the effect of cigarettes with minimal filter ventilation vs. moderate filter ventilation on smoking behavior and biomarkers of tobacco toxicant exposure. Subjective measures, alveolar carbon monoxide, blood pressure and cigarettes per a day will be collected remotely. Biological samples will be collected at home and mailed to the study clinic.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators.
What data supports the effectiveness of the treatment involving different types of cigarettes in reducing health risks?
Research suggests that smokers of lower tar filter cigarettes have reduced mortality rates for several cancers and chronic diseases compared to those who smoke higher tar plain cigarettes. However, the effectiveness of light and ultra-light cigarettes in significantly reducing health risks is questionable due to compensatory smoking behaviors.12345
Is filter ventilation in cigarettes safe for humans?
Filter ventilation in cigarettes has been linked to an increase in lung adenocarcinomas (a type of lung cancer) and may lead to higher exposure to harmful smoke components. It can also create a false sense of safety, as 'light' cigarettes do not significantly reduce health risks compared to regular cigarettes.13567
How does the treatment of using unventilated filter cigarettes differ from other treatments for tobacco use?
Unventilated filter cigarettes differ from other treatments for tobacco use by eliminating the filter ventilation that typically reduces tar and nicotine yields, potentially making cigarettes less appealing and encouraging smoking cessation. This approach contrasts with other treatments that focus on reducing nicotine intake or using alternative nicotine delivery systems.34589
Research Team
Dorothy Hatsukami, PH.D
Principal Investigator
Masonic Cancer Center, University of Minnesota
Eligibility Criteria
This trial is for people over 21 who regularly smoke cigarettes of an eligible brand, are in good health overall, and have access to a smartphone or tablet with a camera and internet for telehealth visits.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Monitoring
Participants undergo 3 weeks of monitoring of usual brand smoking
Treatment
Participants are randomly assigned to smoke either ventilated or unventilated cigarettes for 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Unventilated filter cigarettes
- Ventilated filter cigarettes
Find a Clinic Near You
Who Is Running the Clinical Trial?
Masonic Cancer Center, University of Minnesota
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Ohio State University
Collaborator